세계의 시토신 시장 규모, 점유율 및 동향 분석 보고서 : 최종 용도별, 지역별 전망 및 예측(2023-2030년)
Global Cytosine Market Size, Share & Trends Analysis Report By End-use (Pharmaceutical, Agriculture, Chemical Industry, and Others), By Regional Outlook and Forecast, 2023 - 2030
상품코드:1429065
리서치사:KBV Research
발행일:2024년 01월
페이지 정보:영문 159 Pages
라이선스 & 가격 (부가세 별도)
한글목차
시토신 시장 규모는 예측 기간 동안 CAGR 9.2%로 성장하여 2030년에는 6억 1,240만 달러에 달할 것으로 예상됩니다. 2022년 시장 규모는 1,124.51톤이었고, 8.4%(2019-2022년)의 성장률을 나타낼 것으로 예상됩니다.
그러나 이 화합물은 뉴클레오티드 염기이며, 그 합성에는 복잡한 화학 공정이 필요합니다. 생산에서 고순도 및 고품질을 달성하는 것은 다양한 용도로 사용하기 위해 필수적입니다. 이러한 합성 및 정제 공정의 복잡성은 비용을 증가시켜 제조업체에 도전 과제를 제기합니다. 이 화합물의 효율적이고 높은 처리량을 생산하기 위해서는 최첨단 장비와 인프라가 필수적입니다. 특수 장비, 시설 및 기술을 획득하고 유지하기 위한 초기 투자는 전체 비용 구조에 큰 영향을 미칠 수 있습니다. 이러한 요인으로 인해 향후 몇 년동안 시장 성장이 저해될 것으로 보입니다.
목차
제1장 시장 범위와 조사 방법
시장의 정의
목적
시장 범위
세분화
조사 방법
제2장 시장 요람
주요 하이라이트
제3장 시장 개요
서론
개요
시장 구성과 시나리오
시장에 영향을 미치는 주요 요인
시장 성장 촉진요인
시장 기회
시장 성장 억제요인
시장이 해결해야 할 과제
Porter의 Five Forces 분석
제4장 세계 시장 : 최종 용도별
세계의 의약품 시장 : 지역별
세계의 농업 시장 : 지역별
세계의 화학 산업 시장 : 지역별
세계의 기타 시장 : 지역별
제5장 세계 시장 : 지역별
북미 시장
북미 시장 : 최종 용도별
북미 시장 : 국가별
미국의 시트신 시장
캐나다의 시트신 시장
멕시코의 시트신 시장
기타 북미 시장
유럽 시장
유럽 시장 : 최종 용도별
유럽 시장 : 국가별
독일의 시트신 시장
영국의 시트신 시장
프랑스의 시트신 시장
러시아의 시트신 시장
스페인의 시트신 시장
이타리아시트신 시장
기타 유럽 시장
아시아태평양 시장
아시아태평양 시장 : 최종 용도별
아시아태평양 시장 : 국가별
중국의 시트신 시장
일본의 시트신 시장
인도의 시트신 시장
한국의 시트신 시장
싱가포르의 시트신 시장
말레이시아의 시트신 시장
기타 아시아태평양 시장
라틴아메리카/중동 및 아프리카 시장
라틴아메리카/중동 및 아프리카 시장 : 최종 용도별
라틴아메리카/중동 및 아프리카 시장 : 국가별
브라질의 시트신 시장
아르헨티나의 시트신 시장
아랍에미리트의 시트신 시장
사우디아라비아의 시트신 시장
남아프리카공화국의 시트신 시장
나이지리아의 시트신 시장
기타 라틴아메리카/중동 및 아프리카 시장
제6장 기업 개요
VIVAN Life Sciences Pvt Limited
Central Drug House(P) Ltd
Naugra Export
Marine Chemical
Spectrum Chemical Mfg Corp(Spectrum Laboratory Products, Inc.)
Tokyo Chemical Industry Co, Ltd.
Santa Cruz Biotechnology, Inc
FUJIFILM Wako Pure Chemical Corporation(Fujifilm Holdings Corporation)
제7장 시트신 시장을 위한 성공 필수 조건
LSH
영문 목차
영문목차
The Global Cytosine Market size is expected to reach $612.4 million by 2030, rising at a market growth of 9.2% CAGR during the forecast period. In the year 2022, the market attained a volume of 1,124.51 Tonnes experiencing a growth of 8.4% (2019-2022).
The pharmaceutical industry's focus on developing antiviral and anticancer drugs involves this comound and its derivatives. Cytosine-based compounds are integral in creating pharmaceutical agents that target specific genetic processes, contributing to the rising demand for this compound in these therapeutic areas. Consequently, the pharmaceutical segment would acquire nearly 65% of the total market share by 2030. Additionally, this compound is crucial for modifying and engineering DNA sequences used in gene therapies. As the pharmaceutical sector explores these cutting-edge treatments, the demand for this compound in gene therapy applications expands. Thus, the rising demand for pharmaceuticals, driven by ongoing research and the development of innovative therapies, significantly expands the market.
Advances in gene editing techniques, like CRISPR-Cas9, have revolutionized genetic engineering. This compound is a fundamental component in synthesizing guide RNA molecules used in CRISPR systems. The widespread adoption of CRISPR and other gene editing tools increases the demand for high-quality cytosine in research and therapeutic applications. Genomic medicine, which involves using information from an individual's genome to guide medical decisions, is an area where this compound plays a significant role. Advancements in genomic medicine, such as personalized treatments based on genetic profiles, contribute to the increased demand for this compound in diagnostics and targeted therapies. Thus, the expanding market is closely tied to the continuous advancements in biotechnology. Additionally, Government agencies often provide funding and grants to support biotechnology, genomics, and molecular biology research initiatives. This financial support encourages academic institutions, research organizations, and biotechnology companies to engage in compound-related projects. Collaborations between government entities and private industry players contribute to the growth of the market. Therefore, growing government support and regulatory frameworks provide a foundation for the expansion of the market.
However, this compound is a nucleotide base, and its synthesis involves intricate chemical processes. Achieving high purity and quality in production is essential for its use in various applications. The complexity of these synthesis and purification processes can drive up costs and pose challenges for manufacturers. State-of-the-art equipment and infrastructure are essential for efficient and high-throughput production of this compound. The initial investments in acquiring and maintaining specialized equipment, facilities, and technology can substantially impact the overall cost structure. Due to the above factors, market growth will be hampered in the coming years.
By End-Use Analysis
Based on end-use, the market is segmented into chemical industry, pharmaceutical, agriculture, and others. The agriculture segment acquired a substantial revenue share in the market in 2022. Agriculture is another major product end-user; it is one of the four nucleotide bases in DNA and plays a crucial role in crop improvement and breeding programs. Genetic variations and mutations in this compound & other nucleotide bases are essential for traditional crop breeding, allowing improved crop varieties with desirable traits, like disease resistance, increased yield, and enhanced nutritional content. Polymerase chain reaction (PCR), a widely used technique in molecular biology and genetics, allows for the amplification of specific DNA segments.
By Regional Analysis
Region-wise, the market is analysed across North America, Europe, Asia Pacific, and LAMEA. In 2022, the North America region held the highest revenue share in the market. This is attributed to the high product usage in various industries located in this region, including agriculture and pharmaceuticals. The pharmaceutical industry in North America has recognized the potential of this compound in drug discovery, development, and personalized medicine. The presence of leading biotechnology companies in North America fosters a culture of innovation and research excellence. Ongoing R&D initiatives in genetics, genomics, and personalized medicine drive the demand for this compound as a fundamental component in these scientific endeavors.
List of Key Companies Profiled
Spectrum Chemical Mfg. Corp (Spectrum Laboratory Products, Inc.)
VIVAN Life Sciences Pvt. Limited
Tokyo Chemical Industry Co. Ltd.
Santa Cruz Biotechnology, Inc.
FUJIFILM Wako Pure Chemical Corporation (Fujifilm Holdings Corporation)
Central Drug House (P) Ltd.
Naugra Export
Marine Chemical
Global Cytosine Market Report Segmentation
By End-use (Volume, Tonnes, USD Million, 2019-2030)
Pharmaceutical
Agriculture
Chemical Industry
Others
By Geography (Volume, Tonnes, USD Million, 2019-2030)
North America
US
Canada
Mexico
Rest of North America
Europe
Germany
UK
France
Russia
Spain
Italy
Rest of Europe
Asia Pacific
China
Japan
India
South Korea
Singapore
Malaysia
Rest of Asia Pacific
LAMEA
Brazil
Argentina
UAE
Saudi Arabia
South Africa
Nigeria
Rest of LAMEA
Table of Contents
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Global Cytosine Market, by End-use
1.4.2 Global Cytosine Market, by Geography
1.5 Methodology for the research
Chapter 2. Market at a Glance
2.1 Key Highlights
Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Opportunities
3.2.3 Market Restraints
3.2.4 Market Challenges
3.3 Porter's Five Forces Analysis
Chapter 4. Global Cytosine Market, By End-use
4.1 Global Pharmaceutical Market, By Region
4.2 Global Agriculture Market, By Region
4.3 Global Chemical Industry Market, By Region
4.4 Global Others Market, By Region
Chapter 5. Global Cytosine Market, By Region
5.1 North America Cytosine Market
5.1.1 North America Cytosine Market, By End-use
5.1.1.1 North America Pharmaceutical Market, By Country
5.1.1.2 North America Agriculture Market, By Country
5.1.1.3 North America Chemical Industry Market, By Country
5.1.1.4 North America Others Market, By Country
5.1.2 North America Cytosine Market, By Country
5.1.2.1 US Cytosine Market
5.1.2.1.1 US Cytosine Market, By End-use
5.1.2.2 Canada Cytosine Market
5.1.2.2.1 Canada Cytosine Market, By End-use
5.1.2.3 Mexico Cytosine Market
5.1.2.3.1 Mexico Cytosine Market, By End-use
5.1.2.4 Rest of North America Cytosine Market
5.1.2.4.1 Rest of North America Cytosine Market, By End-use
5.2 Europe Cytosine Market
5.2.1 Europe Cytosine Market, By End-use
5.2.1.1 Europe Pharmaceutical Market, By Country
5.2.1.2 Europe Agriculture Market, By Country
5.2.1.3 Europe Chemical Industry Market, By Country
5.2.1.4 Europe Others Market, By Country
5.2.2 Europe Cytosine Market, By Country
5.2.2.1 Germany Cytosine Market
5.2.2.1.1 Germany Cytosine Market, By End-use
5.2.2.2 UK Cytosine Market
5.2.2.2.1 UK Cytosine Market, By End-use
5.2.2.3 France Cytosine Market
5.2.2.3.1 France Cytosine Market, By End-use
5.2.2.4 Russia Cytosine Market
5.2.2.4.1 Russia Cytosine Market, By End-use
5.2.2.5 Spain Cytosine Market
5.2.2.5.1 Spain Cytosine Market, By End-use
5.2.2.6 Italy Cytosine Market
5.2.2.6.1 Italy Cytosine Market, By End-use
5.2.2.7 Rest of Europe Cytosine Market
5.2.2.7.1 Rest of Europe Cytosine Market, By End-use
5.3 Asia Pacific Cytosine Market
5.3.1 Asia Pacific Cytosine Market, By End-use
5.3.1.1 Asia Pacific Pharmaceutical Market, By Country
5.3.1.2 Asia Pacific Agriculture Market, By Country
5.3.1.3 Asia Pacific Chemical Industry Market, By Country
5.3.1.4 Asia Pacific Others Market, By Country
5.3.2 Asia Pacific Cytosine Market, By Country
5.3.2.1 China Cytosine Market
5.3.2.1.1 China Cytosine Market, By End-use
5.3.2.2 Japan Cytosine Market
5.3.2.2.1 Japan Cytosine Market, By End-use
5.3.2.3 India Cytosine Market
5.3.2.3.1 India Cytosine Market, By End-use
5.3.2.4 South Korea Cytosine Market
5.3.2.4.1 South Korea Cytosine Market, By End-use
5.3.2.5 Singapore Cytosine Market
5.3.2.5.1 Singapore Cytosine Market, By End-use
5.3.2.6 Malaysia Cytosine Market
5.3.2.6.1 Malaysia Cytosine Market, By End-use
5.3.2.7 Rest of Asia Pacific Cytosine Market
5.3.2.7.1 Rest of Asia Pacific Cytosine Market, By End-use
5.4 LAMEA Cytosine Market
5.4.1 LAMEA Cytosine Market, By End-use
5.4.1.1 LAMEA Pharmaceutical Market, By Country
5.4.1.2 LAMEA Agriculture Market, By Country
5.4.1.3 LAMEA Chemical Industry Market, By Country
5.4.1.4 LAMEA Others Market, By Country
5.4.2 LAMEA Cytosine Market, By Country
5.4.2.1 Brazil Cytosine Market
5.4.2.1.1 Brazil Cytosine Market, By End-use
5.4.2.2 Argentina Cytosine Market
5.4.2.2.1 Argentina Cytosine Market, By End-use
5.4.2.3 UAE Cytosine Market
5.4.2.3.1 UAE Cytosine Market, By End-use
5.4.2.4 Saudi Arabia Cytosine Market
5.4.2.4.1 Saudi Arabia Cytosine Market, By End-use
5.4.2.5 South Africa Cytosine Market
5.4.2.5.1 South Africa Cytosine Market, By End-use
5.4.2.6 Nigeria Cytosine Market
5.4.2.6.1 Nigeria Cytosine Market, By End-use
5.4.2.7 Rest of LAMEA Cytosine Market
5.4.2.7.1 Rest of LAMEA Cytosine Market, By End-use
Chapter 6. Company Profiles
6.1 VIVAN Life Sciences Pvt. Limited
6.1.1 Company Overview
6.2 Central Drug House (P) Ltd.
6.2.1 Company Overview
6.3 Naugra Export
6.3.1 Company Overview
6.4 Marine Chemical
6.4.1 Company Overview
6.5 Spectrum Chemical Mfg. Corp (Spectrum Laboratory Products, Inc.)
6.5.1 Company Overview
6.5.2 SWOT Analysis
6.6 Tokyo Chemical Industry Co., Ltd.
6.6.1 Company Overview
6.6.2 SWOT Analysis
6.7 Santa Cruz Biotechnology, Inc.
6.7.1 Company Overview
6.7.2 SWOT Analysis
6.8 FUJIFILM Wako Pure Chemical Corporation (Fujifilm Holdings Corporation)
